Published in Comput Biomed Res on April 01, 1993
First-night effect in normal subjects and psychiatric inpatients. Sleep (1995) 1.34
Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy. Neuropsychopharmacology (2000) 1.14
Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res (1998) 1.07
Sleep stage scoring using the neural network model: comparison between visual and automatic analysis in normal subjects and patients. Sleep (1996) 1.05
Changes in EEG power density during sleep laboratory adaptation. Sleep (1997) 1.01
Difference between evening and morning thyrotropin responses to protirelin in major depressive episode. Arch Gen Psychiatry (1990) 0.99
Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders. Am J Med Genet (1998) 0.94
BalI and MspI polymorphisms of the dopamine D3 receptor gene in African Blacks and Caucasians. Hum Hered (1996) 0.94
Prolactin response to D-fenfluramine and suicidal behavior in depressed patients. Psychiatry Res (2000) 0.93
Influence of thyroid hormones on morning and evening TSH response to TRH in major depression. Biol Psychiatry (1994) 0.87
Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia. Am J Med Genet (1996) 0.86
Thyroid axis activity and serotonin function in major depressive episode. Psychoneuroendocrinology (1999) 0.86
Central effects of acamprosate: part 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in healthy young male volunteers. Psychiatry Res (1998) 0.85
Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour. Psychoneuroendocrinology (2001) 0.83
The human small conductance calcium-regulated potassium channel gene (hSKCa3) contains two CAG repeats in exon 1, is on chromosome 1q21.3, and shows a possible association with schizophrenia. Neurogenetics (1998) 0.83
Temporal relationships between pulsatile cortisol secretion and electroencephalographic activity during sleep in man. Electroencephalogr Clin Neurophysiol (1997) 0.83
Effect of antidepressant medication on morning and evening thyroid function tests during a major depressive episode. Arch Gen Psychiatry (1996) 0.83
Temporal relationship between prolactin secretion and slow-wave electroencephalic activity during sleep. Sleep (1995) 0.82
Multihormonal responses to apomorphine in mental illness. Psychoneuroendocrinology (1995) 0.82
Periodic limb movements and obstructive sleep apneas before and after continuous positive airway pressure treatment. J Sleep Res (1999) 0.81
Restless legs syndrome and low brain iron levels in patients with haemochromatosis. J Neurol Neurosurg Psychiatry (2005) 0.81
Dopaminergic function and the cortisol response to dexamethasone in psychotic depression. Prog Neuropsychopharmacol Biol Psychiatry (2000) 0.81
A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression. Psychopharmacol Bull (1996) 0.81
Temporal link between plasma thyrotropin levels and electroencephalographic activity in man. Neurosci Lett (1995) 0.81
No association between the tyrosine hydroxylase microsatellite marker HUMTH01 and schizophrenia or bipolar I disorder. Psychiatr Genet (1998) 0.81
A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian). Psychopharmacology (Berl) (2005) 0.81
Random number generation by normal, alcoholic and schizophrenic subjects. Psychol Med (1990) 0.80
Morning and evening TSH response to TRH and sleep EEG disturbances in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2001) 0.80
HPA axis dysfunction in depression: correlation with monoamine system abnormalities. Psychoneuroendocrinology (1997) 0.80
[Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders]. Encephale (2003) 0.80
Multihormonal responses to clonidine in patients with affective and psychotic symptoms. Psychoneuroendocrinology (2000) 0.79
Noradrenergic dysfunction and antidepressant treatment response. Eur Neuropsychopharmacol (2001) 0.79
All-night EEG spectral analysis as a tool for the prediction of clinical response to antidepressant treatment. Biol Psychiatry (1995) 0.79
Effects of the selective activation of 5-HT3 receptors on sleep: a polysomnographic study in healthy volunteers. Eur Neuropsychopharmacol (2001) 0.78
Growth hormone response to clonidine and the cortisol response to dexamethasone in depressive patients. Psychiatry Res (1996) 0.78
Statistical Decision Tree: a tool for studying pharmaco-EEG effects of CNS-active drugs. Neuropsychobiology (1994) 0.77
Effect of moclobemide on the psychophysiology of sleep/wake cycles: a neuroelectrophysiological study of depressed patients administered with moclobemide. Int Clin Psychopharmacol (1993) 0.77
Pharmacoelectroencephalographic profile of befloxatone, a new reversible MAO-A inhibitor, in healthy subjects. Neuropsychobiology (1996) 0.76
5-HT2 receptors are partially involved in the relationship between renin release and delta relative power. J Endocrinol Invest (1996) 0.76
Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients. Psychopharmacology (Berl) (1993) 0.76
Joint time and time-frequency optimal detection of K-complexes in sleep EEG. Comput Biomed Res (1998) 0.76
Serotonergic and noradrenergic function in depression: clinical correlates. Dialogues Clin Neurosci (2000) 0.76
Disturbances in hypothalamo pituitary adrenal and thyroid axis identify different sleep EEG patterns in major depressed patients. J Psychiatr Res (2002) 0.76
Suicidal behavior in schizophrenia and family history of suicide. Dialogues Clin Neurosci (2001) 0.75
Treating negative symptoms. Br J Psychiatry (1994) 0.75
[The impact of substitution treatment by methadone among opiate-dependent subjects evaluated by Addiction Severity Index and by urine tests]. Encephale (2002) 0.75
[Simultaneous phlebotomography of the cavernous sinus]. Neurochirurgie (1972) 0.75
Low-dimensional dynamic self-organization in delta-sleep: effect of partial sleep deprivation. Biol Cybern (1996) 0.75
Slow wave electroencephalic activity parallels renin oscillations during sleep in humans. Electroencephalogr Clin Neurophysiol (1995) 0.75
Lithium: clinical study by brain electrical activity mapping. A case report. Pharmacopsychiatry (1987) 0.75
Circadian effects on the TSH response to TRH in depressed patients. Clin Neuropharmacol (1992) 0.75
[Effect of pyridoxylate in long term anoxia]. Nouv Presse Med (1972) 0.75
[Nosographic divergences and semeiologic convergences. A unified approach within the framework of a protocol of psychologico-clinical and biological exploration]. Ann Med Psychol (Paris) (1985) 0.75
Noninvasive in vivo detection of a fluorinated neuroleptic in the human brain by 19F nuclear magnetic resonance spectroscopy. Psychiatry Res (1990) 0.75
Collagen-derived heart valves; concept and experimental results. J Thorac Cardiovasc Surg (1971) 0.75
Analysis of the CAG repeats in the SCA1 and B37 genes in schizophrenic and bipolar I disorder patients: tentative association between B37 and schizophrenia. Am J Med Genet (1997) 0.75
[Hospital stress in adult cardiac surgery]. Soins (1983) 0.75
[Unipolar-bipolar distinction. The genetic arguments]. Encephale (1992) 0.75
[Emergency therapies in psychiatry. Indications, precautions and contra-indications]. Soins Psychiatr (1991) 0.75
Characterization of the CNS effects of naftidrofuryl (Praxilène) by quantitative EEG and functional MRI: a study in healthy elderly subjects. Neuropsychobiology (2003) 0.75
A statistical evaluation of the main interpolation methods applied to 3-dimensional EEG mapping. Electroencephalogr Clin Neurophysiol (1991) 0.75
[Utilization of biopolymers in the construction of cardiac valve prostheses]. C R Acad Sci Hebd Seances Acad Sci D (1971) 0.75
An architecture for EEG signal processing and interpretation during sleep (ESPIS). Comput Methods Programs Biomed (1994) 0.75
[Teaching medical psychology to medical students from the first years: apropos of the dangers of the teaching but also its value. Its relation to teaching psychiatry]. Ann Med Psychol (Paris) (1980) 0.75